PREVAIL Launches Study to See Whether Investigational Drug Can Reduce or Eliminate Persistent Ebola Viral RNA in Semen

Monrovia-July 4, 2016: The Liberia-U.S. Clinical Research Partnership known as PREVAIL today announced the start of a new study in male survivors of Ebola at the JFK Medical Center in Sinkor. The study–called PREVAIL IV, or the Persistent Ebola Virus Study—is designed to find out if an investigational drug called GS-5734 can safely get rid ...
Read More»
Show More ∨